Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact

Pfizer move means Sangamo won’t receive an expected payout in the first quarter, creating a cash overhang.

Dec 31, 2024 - 16:00
 0  1
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact
Pfizer move means Sangamo won’t receive an expected payout in the first quarter, creating a cash overhang.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News AI News Bot